• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CMV IGG, IGG ANTIBODIES TO CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CMV IGG, IGG ANTIBODIES TO CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS Back to Search Results
Catalog Number 04784596190
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/15/2016
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).Unique identifier (udi)#: (b)(4).
 
Event Description
The customer stated that they have received an erroneous high result for one patient sample tested for the elecsys (b)(6) on a cobas 6000 e 601 module (e601).The erroneous result was reported outside of the laboratory.A first sample from the patient was tested on an e601 in the customer's laboratory on (b)(6) 2015 and resulted as 5.7 u/ml ((b)(6)) for (b)(6).The result was obtained during the patient's first pregnancy and was not questioned.A second sample from the patient was tested in a second laboratory on an abbott architect analyzer on (b)(6) 2016, resulting as 0.4 au/ml ((b)(6)) for (b)(6).A third sample from the patient was tested on the customer's e601 analyzer (serial number (b)(4)) on (b)(6) 2016 and the result was 27 u/ml ((b)(6)) for (b)(6).This sample was repeated at a third laboratory on an abbott architect analyzer on (b)(6) 2016, resulting as (b)(6) for (b)(6).The customer does not know if the patient is (b)(6) for (b)(6).The patient was not adversely affected.
 
Manufacturer Narrative
A sample from the patient was provided for investigation.Investigations were able to duplicate the results of the customer.The sample showed clear reactivity with the roche cmvigg assay.There was no evidence for systemic interference of the sample with the general assay components.Antigen specific interference also appeared to be unlikely.The presence of cmv specific igg antibodies is supported by the recomline cmv igg assay, however, the detected signals are below the assay's cutoff (borderline result).The cmv specific igg antibodies were determined to be of high avidity (101%).This suggests that the patient had been remotely infected with cmv and has already acquired specific immunity.The root cause of the observed discrepancy between the roche cmvigg assay and the abbott assay could not be determined.Further testing of the patient with other independent methods, together with information on the clinical history of the patient may help to refine the diagnostic cmv status.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CMV IGG, IGG ANTIBODIES TO CYTOMEGALOVIRUS
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key6300774
MDR Text Key66507244
Report Number1823260-2017-00213
Device Sequence Number1
Product Code LFZ
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
K131605
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/24/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2017
Device Catalogue Number04784596190
Device Lot Number174473
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/09/2017
Initial Date FDA Received02/03/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/24/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age39 YR
-
-